Company intelligence / Profile preview

Scientia Ventures Funds

Ownership
Private
Development stage
Other
01

Overview

Scientia Ventures Funds appears to be an investment organization rather than a drug-development operating company. Based on the name, it is most likely a venture capital or fund vehicle focused on science-driven or healthcare-related investments. There is no reliable evidence available here that it directly develops therapeutics, runs a clinical pipeline, or commercializes healthcare products. As such, it should be treated primarily as a financing entity in the broader life sciences ecosystem rather than a biotech or pharmaceutical developer.

Industry
Investors

Beyond the preview

Go deeper on Scientia Ventures Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scientia Ventures Funds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call